Dr. Reddy’s shares spike after favourable generic drug ruling

Shares of Indian drugmaker Dr. Reddy’s Laboratories Ltd jumped nearly 9 percent on Wednesday, their sharpest intraday gain in a year, after a U.S. court allowed the company to sell a copycat version of Indivior Plc’s opioid treatment Suboxone Film.

The U.S. Court of Appeals for the Federal Circuit lifted a preliminary injunction that blocked Dr. Reddy’s from selling the generic, saying a lower court judge erred in granting the request. Shares of Indivior tanked about 47 percent on Tuesday, in a record single-day fall.

“As a result of today’s ruling, Dr. Reddy’s will resume its launch activities as soon as permitted,” the Hyderabad-based generic drugmaker said late on Tuesday.

Investors welcomed the news, with shares of Dr. Reddy’s reaching their highest in nearly two months – 2,655 rupees.

Close to 2.5 million shares had changed hands by 0437 GMT, more than triple the 30-day average of about 788,000 shares.

The stock was the top percentage gainer on the NSE index, which was down 0.7 percent, and helped the Nifty pharma index rise by 1.3 percent.

Jefferies analysts said they consider the ruling to be near-term positive, and one that allows the company to immediately re-launch the product, but still at-risk.

Nomura analysts said they believe DR. Reddy’s is likely to be compensated in due course for the preliminary injunction, but await clarity whether the compensation could be higher than $72 million.

  • Related Posts

    • Pharma
    • March 27, 2024
    • 105 views
    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

    • Pharma
    • March 27, 2024
    • 69 views
    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down